Hi, it’s Dong Cao and Manuel Baigorri in Hong Kong, looking at how some big-name international brands are reassessing their approach to business in China. Also today, Eli Lilly’s latest move to build its drug pipeline in heart disease. Today’s top stories
www.bloomberg.com
#Starbucks #Rethink #Recipe #Success #China
Starbucks and Others Rethink Recipe for Success in China
